In this instalment of Robert MacNeill’s column, he explores hydrophilic-interaction liquid chromatography (HILIC) and how the technique is often overlooked.
Browsing: Expert columns
As the COVID-19 pandemic extends its reach worldwide, the demand for available, accurate testing is growing exponentially. Science News reports that COVID-19 testing has been available in limited quantities from the Centers for Disease Control (CDC), but production has not been able to keep up with demand.
With coronavirus disease 2019 (COVID-19) shutting down countries and economies, the world is expectantly looking at scientists to come up with a solution.
This exclusive editorial explores the very recent and very exciting developments in the field of single cell proteomics. Is now the time to realize the potential of SCoPE-MS?
In this instalment of Robert Macneill’s (Covance) column, Robert explores the potential information to be gleaned from calibration curves and how these insights could possibly fuel innovation in the field of biomarker quantification.
A rapid mobile-based assay for determination of inflammation through quantification of alpha-1-acid glycoprotein has been developed.
In this installment of Robert MacNeill’s (Covance) column, Robert discusses the potential disparity in results when using a given method for extracted analytical batches versus in solution, the different challenges involved with solutions and extracts and the necessity to fully consider the relevant chemistry from the earliest stages of method development.
Brexit or no Brexit? The question that has been weighing on the UK for the past 3 years will soon have an answer (hopefully). Read this commentary from Zamas Lam (QPS; DE, USA) discussing how Brexit relates to the future of drug discovery, preclinical and clinical drug development.
In this installment of Robert MacNeill’s (Covance) column, Robert discusses where to best place specific QC samples within a calibration range for a methodology, and the challenges associated with establishing suitable nominal levels for the internal standard concentration.
With the reality of Brexit already impacting the UK’s clinical trials environment, Zamas Lam (QPS; DE, USA) discusses the effect this will have on bioanalytical research, and suggests 10 questions to ask when relocating UK-based preclinical and bioanalysis research projects.